08.09.2021 15:00:56
|
Bluebird Bio Secures $75 Mln In Private Placement Equity Financing
(RTTNews) - bluebird bio Inc. (BLUE) said Wednesday that it has reached an agreement for a $75 million private placement of common stock and common stock equivalents with a healthcare investment fund selected as part of a competitive process.
bluebird bio noted that proceeds from the financing will support ongoing R&D and commercialization investments for bluebird bio and for 2seventy bio. The closing of the private placement is expected to occur in September 2021.
bluebird plans to complete the spin-off of 2seventy in October 2021.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu bluebird bio Incmehr Nachrichten
Keine Nachrichten verfügbar. |